Sort
39,280 grants matching “leukemia”
Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia.
$711,288Elliot Stieglitz · University Of California, San Francisco · R37 · FY2022 · CA
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
$711,258Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Missouri Valley Cancer Consortium CCOP
$711,123Gamini Soori · Cancer Alliance Of Nebraska · U10 · FY2014 · CA
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
$710,976Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
$710,976Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2016 · CA
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
$710,976Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2015 · CA
Gene Therapy in Hematopoietic Cells
$710,951Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · P01 · FY2009 · HL
Prevention of Heart Failure induced by Doxorubicin with Early Administration of Dexrazoxane
$710,737Hui-Ming Chang · Univ Of Arkansas For Med Scis · R01 · FY2023 · HL
DNA Mismatch Repair
$710,681Peggy Hsieh · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
$710,483Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Cincinnati Neuro-Oncology Research Core
$710,000Nancy Ratner · Cincinnati Childrens Hosp Med Ctr · P30 · FY2010 · CA
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
$709,841Katharine C Hsu · Sloan-Kettering Inst Can Research · R01 · FY2024 · AI
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
$709,841Katharine C Hsu · Sloan-Kettering Inst Can Research · R01 · FY2022 · AI
FUNCTION OF LACTOSAMINYL GLYCANS IN EARLY HEMATOPOIETIC AND MYELOPOIETIC CELLS
$709,767Robert Sackstein · Brigham And Women'S Hospital · P01 · FY2015 · HL
A beneficial persistent DNA damage-induced immune response in aging
$709,654Wei Du · University Of Pittsburgh At Pittsburgh · R56 · FY2024 · HL
Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemia
$709,633Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2025 · CA
Innate Restriction Factor Modulation of Retrovirus-specific Humoral Immunity
$709,630Mario Luis Santiago · University Of Colorado Denver · R01 · FY2011 · AI
Administrative Core
$709,629Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2021 · CA
Inhibition of p53 Tumor Suppressor Function by HTLV-I
$709,332John N. Brady · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Improving risk allocation and developing novel therapies for children with T-ALL
$709,314David T. Teachey · Children'S Hosp Of Philadelphia · R01 · FY2015 · CA
Development of new therapeutic approaches for endometrial cancer
$709,125Suryavathi Viswanadhapalli · University Of Texas Hlth Science Center · R01 · FY2025 · CA
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneichematopoietic cell transplantation
$709,029Brian C Betts · Roswell Park Cancer Institute Corp · R01 · FY2024 · HL
Role of Genetic Susceptibility in Therapy-related Subsequent Malignancies
$708,614Smita Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2010 · CA
Structure and Function of Vif and APOBEC3 (A3) Proteins
$708,607Vinay K. Pathak · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Investigating hematopoietic stem cell dysfunction during sickle cell disease
$708,579Shannon L McKinney-Freeman · St. Jude Children'S Research Hospital · R01 · FY2023 · HL